Partners News Cell4Pharma enters into distribution agreement and strategic partnership with MatTek

25 March 2022

MatTek Life Sciences, a Boston-area tissue engineering company and a member of the BICO Group, announced today it has entered into a distribution agreement and strategic partnership with Radboudumc’s spin-off company Cell4Pharma, a company specializing in commercially available human renal cells, to distribute its products in the US as well as develop a new in vitro kidney model. “The strategic partnership with MatTek is in line with our goal to accelerate our growing global network of strategic partners. This partnership supports our mission to support human-relevant research by providing synergistic life science products and services,” said Ron Byron, CEO of Cell4Pharma. Read full article here: MatTek Enters Distribution Agreement and Strategic Partnership with Cell4Pharma (bico.com)

Related news items


Enzyre closes Series A financing round of €12M to advance pioneering diagnostic technology platform for hemophilia patients

2 November 2022

Enzyre has announced that it has successfully raised €12 million in a Series A financing led by new investor, Oost NL, with participation from i&i Biotech Fund, Demcon Investment, Takeda Ventures, and Novalis Biotech. Part of the funding is an Innovation Credit from the Dutch Government.

read more

Successful matchmaking at Radboudumc Investment Day  

7 October 2022

On the 5th of October, over 100 scientists, investors and entrepreneurs came together at the second Radboudumc Investment Day, jointly hosted by Radboudumc, Oost NL and Briskr.

read more

SPL Medical announces collaboration with NanoEcho for application of Ferrotran® (Ferumoxtran) for Ultrasound detection of Lymph node metastases

30 September 2022

SPL medical and NanoEcho have signed a Letter of Intent and initiated a cooperation on regulatory partnership and supply for SPL medical proprietary iron-based nanoparticle Ferrotran® (Ferumoxtran) product and platform.

read more

Radboudumc Investment Day 2022

26 September 2022

Get ready for Radboudumc Investment Day 2022: October 5 in Nijmegen!

read more

Innovation by Predica Diagnostics BV improves cervical cancer screening

26 July 2022

A joint financing round from ION+2 and the Thematic Technology Transfer Medtech Fund (TTT Medtech) allows the further development of molecular diagnostic tests for different cancers by Predica Diagnostics (Nijmegen, NL).

read more

Meet BabyChecker!

24 September 2021 On September 20th, 2021, Delft Imaging launched BabyChecker: an affordable and portable smartphone-based ultrasound solution. read more